John Rubenstein, MD, PhD

Residency, 1991 - Psychiatry, Stanford
Postdoc, 1986 - Mouse Embryology, Pasteur Institute
MD, 1986 - , Stanford
Biophysics, 1982 - Membrane Structure and Biogenesis, Stanford
BS, 1977 - Chemistry, Stanford

Neocortex

Homeodomain Proteins

Body Patterning

COUP Transcription Factor I

Interneurons

Transcription Factors

Nerve Tissue Proteins

Prosencephalon

Genes, Homeobox

GABAergic Neurons

Enhancer Elements, Genetic

Cerebral Cortex

Fibroblast Growth Factors

Telencephalon

Gene Expression Regulation, Developmental

W. Maxwell Cowan Award for Developmental Neuroscience, J. Comparative Neurology, 2021
National Academy of Sciences, 2020
Ted Jones Neuroscience Lecture, UC Davis, 2018
National American Academy of Arts and Sciences, 2016
Ittleson Award for Research in Child and Adolescent Psychiatry, American Psychiatric Association, 2016
Ruane Prize for Outstanding Child and Adolescent Psychiatric Research, Brain & Behavior Research Foundation, 2016
Distinguished Scientist Award, Child Mind Institute, 2015
Heinrich Waelsch Memorial Neuroscience Lecturer, Columbia School of Medicine, 2015
Pinckney J. Harman Memorial Award in Cortical Development, Cajal Club, 2014
Faculty Lecturer Basic Science, UCSF, 2013
Royer Award for Excellence in Academic Psychiatry, UCSF, 2012
Cajal Club President, Cajal Club, 2008
National Academy of Medicine, 2006
Krieg Cortical Discoverer Award, Cajal Club, 2004
Phi Beta Kappa, Stanford University, 1997
Presidential Scholar Award for Research, AACAP, 1991
Honor in Chemistry, Stanford University, 1977

January 31, 2018 - Gene Enhancers Are Important Despite Apparent Redundancy

May 23, 2012 - Chronic Pain is Relieved by Cell Transplantation in Lab Study

February 18, 2016 - Rubenstein recognized with trio of honors

April 24, 2026 - December 31, 2030 - Genetic Control of Basal Telencephalic Development , Principal Investigator .

May 1, 2023 - January 31, 2028 - Neurodevelopmental defects of the thalamocortical pathway as a convergent feature of psychiatric disorders , Co-Principal Investigator .

September 30, 2016 - June 30, 2026 - Genetic Studies of Cortex Structure and Development , Principal Investigator .

December 1, 2007 - November 30, 2023 - Genetic Control of Basal Telencephalic Development , Principal Investigator .

June 1, 1992 - November 30, 2022 - Genetic Regulation of Telencephalon Development , Principal Investigator .

September 26, 2014 - May 31, 2018 - Identification of enhancers whose activity defines cortical interneuron types , Principal Investigator .

June 1, 1992 - November 30, 2017 - Genetic Regulation of Telencephalon Development , Principal Investigator .

September 1, 1996 - January 31, 2017 - Genetic Studies of Cortex Structure and Development , Principal Investigator .

March 1, 1982 - May 31, 2015 - Bio-Organic Biomedical Mass Spectrometry Resource , Co-Investigator .

January 1, 2003 - December 31, 2007 - Genetic Regulation of Telencephalon Development , Principal Investigator .

January 1, 2003 - December 31, 2007 - Regulation of craniofacial development by the Dix genes. , Principal Investigator .

May 1, 1999 - February 28, 2005 - NKX HOMEOBOX GENE REGULATION OF VENTRAL CNS DEVELOPMENT , Principal Investigator .

September 30, 1994 - May 31, 2003 - FUNCTION OF DLX GENES IN FOREBRAIN DEVELOPMENT , Principal Investigator .

January 1, 1993 - December 31, 2002 - GENETIC REGULATION OF TELENCEPHALON DEVELOPMENT , Principal Investigator .

Combinatorial transcription factor binding encodes cis-regulatory wiring of mouse forebrain GABAergic neurogenesis.

Tuesday, October 29th, 2024

Nr2f1 enhancers have distinct functions in controlling Nr2f1 expression during cortical development.

Sunday, September 22nd, 2024

Five autism-associated transcriptional regulators target shared loci proximal to brain-expressed genes.

Thursday, June 6th, 2024

Education

Interests

Honors and Awards

Media Links

Research Activities and Funding

Publications

Contact information